Antibiotic Discovery: Where Have We Come from, Where Do We Go?
Bernardo Ribeiro da Cunha, Luís P. Fonseca, Cecília R. C. Calado · Antibiotics · 2019 · Review
Full textCC BY
Pharmacology
Filters3 filters applied
Year
Readable here
Study type
Licence
An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases
Nand Kishor Roy, Dey Parama, Kishore Banik et al. · International Journal of Molecular Sciences · 2019 · Review
Full textCC BY
Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
Joshua Brown, Almut Winterstein · Journal of Clinical Medicine · 2019 · Review
Full textCC BY
Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to Humans
Jürgen B. Bulitta, William W. Hope, Ann E. Eakin et al. · Antimicrobial Agents and Chemotherapy · 2019 · Review
Full textCC BY
Exploring Structural Diversity of Microbe Secondary Metabolites Using OSMAC Strategy: A Literature Review
Rui Pan, Xuelian Bai, Jianwei Chen et al. · Frontiers in Microbiology · 2019 · Review
Full textCC BY
Natural Products from Cyanobacteria: Focus on Beneficial Activities
Justine Demay, Cécile Bernard, Anita Reinhardt et al. · Marine Drugs · 2019 · Review
Full textCC BY
Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials
Vaclav Vetvicka, Luca Vannucci, Petr Sima et al. · Molecules · 2019 · Review
Full textCC BY
Kaempferol: A Key Emphasis to Its Anticancer Potential
Muhammad Imran, Bahare Salehi, Javad Sharifi-Rad et al. · Molecules · 2019 · Review
Full textCC BY
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes
Stephen P H Alexander, Doriano Fabbro, Eamonn Kelly et al. · British Journal of Pharmacology · 2019 · Review
Full textCC BY
Extending the “One Strain Many Compounds” (OSMAC) Principle to Marine Microorganisms
Stefano Romano, Stephen A. Jackson, Sloane Patry et al. · Marine Drugs · 2018 · Review
Full textCC BY
The Pathogenesis of Diabetes Mellitus by Oxidative Stress and Inflammation: Its Inhibition by Berberine
Xueling Ma, Zhongjun Chen, Le Wang et al. · Frontiers in Pharmacology · 2018 · Review
Full textCC BY
Cannabinoids and Pain: New Insights From Old Molecules
Sonja Vučković, Dragana Srebro, Katarina Savić Vujović et al. · Frontiers in Pharmacology · 2018 · Review
Full textCC BY
Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy
Thaiane Coelho dos Santos, Thaís Mota Gomes, Bruno Araújo Serra Pinto et al. · Frontiers in Pharmacology · 2018 · Review
Full textCC BY
Recognition and Treatment of Cognitive Dysfunction in Major Depressive Disorder
Hannah Zuckerman, Zihang Pan, Caroline Park et al. · Frontiers in Psychiatry · 2018 · Review
Full textCC BY
Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drugs: An Under-Recognized Public Health Issue
Zoltan Varga, Syed rafay ali Sabzwari, Veronika Vargova · Cureus · 2017 · Review
Full textCC BY
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
Alline C. Campos, Manoela V. Fogaça, Franciele F. Scarante et al. · Frontiers in Pharmacology · 2017 · Review
Full textCC BY
Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
Tommaso Cassano, Silvio Calcagnini, Lorenzo Pace et al. · Frontiers in Neuroscience · 2017 · Review
Full textCC BY
The Safety of Ingested Caffeine: A Comprehensive Review
Jennifer L. Temple, Christophe Bernard, Steven E. Lipshultz et al. · Frontiers in Psychiatry · 2017 · Review
Full textCC BY
Bioactive Mushroom Polysaccharides: A Review on Monosaccharide Composition, Biosynthesis and Regulation
Qiong Wang, Feng Wang, Zhenghong Xu et al. · Molecules · 2017 · Review
Full textCC BY
Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs
Rona Ramsay, Keith Tipton · Molecules · 2017 · Review
Full textCC BY